XTX Topco’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.9K | Sell |
23,914
-48,498
| -67% | -$150K | ﹤0.01% | 1938 |
|
|
2025
Q1 | $253K | Buy |
72,412
+19,831
| +38% | +$69.2K | 0.01% | 1536 |
|
|
2024
Q4 | $172K | Buy |
52,581
+22,568
| +75% | +$73.8K | 0.01% | 1605 |
|
|
2024
Q3 | $116K | Buy |
30,013
+12,975
| +76% | +$50K | 0.01% | 1576 |
|
|
2024
Q2 | $52.6K | Buy |
+17,038
| New | +$52.6K | ﹤0.01% | 1507 |
|
|
2022
Q4 | – | Sell |
-39,755
| Closed | -$76K | – | 1075 |
|
|
2022
Q3 | $76K | Sell |
39,755
-63,527
| -62% | -$121K | 0.02% | 985 |
|
|
2022
Q2 | $280K | Buy |
103,282
+92,494
| +857% | +$251K | 0.11% | 299 |
|
|
2022
Q1 | $32K | Sell |
10,788
-18,238
| -63% | -$54.1K | 0.01% | 615 |
|
|
2021
Q4 | $113K | Buy |
29,026
+17,422
| +150% | +$67.8K | 0.06% | 449 |
|
|
2021
Q3 | $50K | Buy |
+11,604
| New | +$50K | 0.02% | 604 |
|